BullFrog AI Holdings, Inc. Logo

BullFrog AI Holdings, Inc.

Leverages causal AI to accelerate drug discovery and identify novel targets for biopharmaceuticals.

BFRG | US

Overview

Corporate Details

ISIN(s):
US12021E1091
LEI:
Country:
United States of America
Address:
325 ELLINGTON BLVD., 20878 GAITHERSBURG
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

BullFrog AI Holdings, Inc. is a technology-enabled biopharmaceutical company that leverages artificial intelligence (AI) and machine learning (ML) to enhance the drug discovery and development process. The company utilizes a proprietary platform featuring causal AI and graph-based analytics to model complex biological systems. This technology enables the rapid and cost-effective identification and validation of novel drug targets, aiming to generate actionable insights from complex data. By supporting both internal and external drug development programs, BullFrog AI's mission is to accelerate research, lower costs, and significantly improve the success rate of bringing new therapeutics to market.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all BullFrog AI Holdings, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for BullFrog AI Holdings, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for BullFrog AI Holdings, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

SanBio Company Limited Logo
Developing regenerative cell therapies for severe neurological disorders like brain injury and stroke.
Japan
4592
SANGAMO THERAPEUTICS, INC Logo
Developing genomic cures for severe genetic diseases using proprietary zinc finger technology.
United States of America
SGMO
S.Biomedics Co., Ltd. Logo
South Korea
304360
SCANCELL HOLDINGS PLC Logo
Developing therapeutic vaccines and antibodies for cancer and infectious diseases.
United Kingdom
SCLP
Scandion Oncology A/S Logo
Biotech company in liquidation, formerly developing therapies to overcome cancer drug resistance.
Denmark
SCOL
Scanway Spolka Akcyjna Logo
Develops optical instruments for space and AI vision systems for industrial quality control.
Poland
SCW
Scholar Rock Holding Corp Logo
Biopharma developing medicines for neuromuscular diseases by targeting protein growth factors.
United States of America
SRRK
Schrodinger, Inc. Logo
A physics-based computational platform for accelerated drug and materials discovery.
United States of America
SDGR
South Korea
246960
Scope Fluidics S.A. Logo
Biotech venture builder creating microfluidic diagnostic systems for healthcare.
Poland
SCP

Talk to a Data Expert

Have a question? We'll get back to you promptly.